Clears Pathway for Execution of Future R&D Milestone Events such as the Phase 1b, FIH Study for PRP in up to 50 Advanced Cancer Patients with Solid Tumors, First Quarter, 2027MELBOURNE, Australia, Oct ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company ...

Shareholders approved both the corporate name change and reverse stock split at a special meeting of shareholders that was held on October 16, 2026.

Enlivex (ENLV) will implement a 1-for-16 reverse stock split effective October 27, 2026, with shares trading on a split-adjusted basis on Nasdaq. The company’s issued and outstanding shares will ...

JUPITER, FL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative ...

The Board of Trustees of Aberdeen Multi-Market Income Fund (NYSE: MMT) has approved a 1-for-4 reverse stock split of the Fund's issued and outstanding common shares, effective prior to the opening of ...

AUSTIN, Texas--(BUSINESS WIRE)--Upland Software, Inc. (Nasdaq: UPLD) (the “Company” or “Upland”), today announced that it will effect a one-for-ten reverse stock split (“reverse split”) of its common ...

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a healthcare technology and biopharmaceutical company operating Lōkahi Therapeutics™, today announced that it will effect a 1-for-2 ...

MIAMI BEACH, Fla.--(BUSINESS WIRE)--LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, today announced that the ...

MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (Nasdaq: BRTX) (“BioRestorative” or the “Company”), a late-stage clinical regenerative medicine company, today ...

Market Income Fund (MMT) said on Friday that its board approved a 1-for-4 reverse stock split of the fund's issued and outstanding common shares, effective November 9, 2026. The board approved the ...